194 related articles for article (PubMed ID: 33404643)
1. High Prevalence of Molecular Markers of Plasmodium falciparum Resistance to Sulphadoxine-Pyrimethamine in Parts of Ghana: A Threat to ITPTp-SP?
Afutu LL; Boampong JN; Quashie NB
J Trop Pediatr; 2021 Jan; 67(1):. PubMed ID: 33404643
[TBL] [Abstract][Full Text] [Related]
2. Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya.
Iriemenam NC; Shah M; Gatei W; van Eijk AM; Ayisi J; Kariuki S; Vanden Eng J; Owino SO; Lal AA; Omosun YO; Otieno K; Desai M; ter Kuile FO; Nahlen B; Moore J; Hamel MJ; Ouma P; Slutsker L; Shi YP
Malar J; 2012 Jul; 11():134. PubMed ID: 22540158
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.
Koukouikila-Koussounda F; Bakoua D; Fesser A; Nkombo M; Vouvoungui C; Ntoumi F
Infect Genet Evol; 2015 Jul; 33():32-6. PubMed ID: 25934142
[TBL] [Abstract][Full Text] [Related]
4. Increase in the prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso.
Ruizendaal E; Tahita MC; Geskus RB; Versteeg I; Scott S; d'Alessandro U; Lompo P; Derra K; Traore-Coulibaly M; de Jong MD; Schallig HDFH; Tinto H; Mens PF
Malar J; 2017 Apr; 16(1):179. PubMed ID: 28454537
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine among pregnant women at first antenatal clinic attendance and delivery in the forest-savannah area of Ghana.
Dosoo DK; Bailey JA; Asante KP; Oppong FB; Niaré K; Opoku-Mensah J; Owusu-Agyei S; Greenwood B; Chandramohan D
PLoS One; 2022; 17(8):e0271489. PubMed ID: 35939419
[TBL] [Abstract][Full Text] [Related]
6. Sulfadoxine-pyrimethamine parasitological efficacy against Plasmodium falciparum among pregnant women and molecular markers of resistance in Zambia: an observational cohort study.
Chaponda EB; Mharakurwa S; Michelo C; Bruce J; Chandramoha D; Matthew Chico R
Malar J; 2021 Jan; 20(1):61. PubMed ID: 33482823
[TBL] [Abstract][Full Text] [Related]
7. Intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine and parasite resistance: cross-sectional surveys from antenatal care visit and delivery in rural Ghana.
Mama A; Ahiabor C; Tornyigah B; Frempong NA; Kusi KA; Adu B; Courtin D; Houzé S; Deloron P; Ofori MF; Anang AK; Ariey F; Ndam NT
Malar J; 2022 Mar; 21(1):107. PubMed ID: 35346205
[TBL] [Abstract][Full Text] [Related]
8. Surveillance of molecular markers of Plasmodium falciparum resistance to sulphadoxine-pyrimethamine 5 years after the change of malaria treatment policy in Ghana.
Duah NO; Quashie NB; Abuaku BK; Sebeny PJ; Kronmann KC; Koram KA
Am J Trop Med Hyg; 2012 Dec; 87(6):996-1003. PubMed ID: 23045251
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of pfdhfr and pfdhps mutations in Plasmodium falciparum associated with drug resistance among pregnant women receiving IPTp-SP at Msambweni County Referral Hospital, Kwale County, Kenya.
Gikunju SW; Agola EL; Ondondo RO; Kinyua J; Kimani F; LaBeaud AD; Malhotra I; King C; Thiong'o K; Mutuku F
Malar J; 2020 May; 19(1):190. PubMed ID: 32448228
[TBL] [Abstract][Full Text] [Related]
10. Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin.
Bertin G; Briand V; Bonaventure D; Carrieu A; Massougbodji A; Cot M; Deloron P
Malar J; 2011 Jul; 10():196. PubMed ID: 21767415
[TBL] [Abstract][Full Text] [Related]
11. Analysis of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum isolates obtained from asymptomatic pregnant women in Ogun State, Southwest Nigeria.
Fagbemi KA; Adebusuyi SA; Nderu D; Adedokun SA; Pallerla SR; Amoo AOJ; Thomas BN; Velavan TP; Ojurongbe O
Infect Genet Evol; 2020 Nov; 85():104503. PubMed ID: 32805431
[TBL] [Abstract][Full Text] [Related]
12. Intermittent preventive treatment comparing two versus three doses of sulphadoxine pyrimethamine (IPTp-SP) in the prevention of anaemia in pregnancy in Ghana: A cross-sectional study.
Agyeman YN; Newton S; Annor RB; Owusu-Dabo E
PLoS One; 2021; 16(4):e0250350. PubMed ID: 33878140
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of dhfr and dhps molecular markers in Plasmodium falciparum in pregnant women of Nchelenge district, Northern Zambia.
Siame MN; Mharakurwa S; Chipeta J; Thuma P; Michelo C
Malar J; 2015 May; 14():190. PubMed ID: 25943379
[TBL] [Abstract][Full Text] [Related]
14. High multiple mutations of Plasmodium falciparum-resistant genotypes to sulphadoxine-pyrimethamine in Lagos, Nigeria.
Quan H; Igbasi U; Oyibo W; Omilabu S; Chen SB; Shen HM; Okolie C; Chen JH; Zhou XN
Infect Dis Poverty; 2020 Jul; 9(1):91. PubMed ID: 32653033
[TBL] [Abstract][Full Text] [Related]
15. Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana.
Mockenhaupt FP; Teun Bousema J; Eggelte TA; Schreiber J; Ehrhardt S; Wassilew N; Otchwemah RN; Sauerwein RW; Bienzle U
Trop Med Int Health; 2005 Sep; 10(9):901-8. PubMed ID: 16135198
[TBL] [Abstract][Full Text] [Related]
16. Presence of quintuple dhfr N51, C59, S108 - dhps A437, K540 mutations in Plasmodium falciparum isolates from pregnant women and the general population in Nanoro, Burkina Faso.
Ruizendaal E; Tahita MC; Traoré-Coulibaly M; Tinto H; Schallig HDFH; Mens PF
Mol Biochem Parasitol; 2017 Oct; 217():13-15. PubMed ID: 28818675
[TBL] [Abstract][Full Text] [Related]
17. The A581G Mutation in the Gene Encoding Plasmodium falciparum Dihydropteroate Synthetase Reduces the Effectiveness of Sulfadoxine-Pyrimethamine Preventive Therapy in Malawian Pregnant Women.
Gutman J; Kalilani L; Taylor S; Zhou Z; Wiegand RE; Thwai KL; Mwandama D; Khairallah C; Madanitsa M; Chaluluka E; Dzinjalamala F; Ali D; Mathanga DP; Skarbinski J; Shi YP; Meshnick S; ter Kuile FO
J Infect Dis; 2015 Jun; 211(12):1997-2005. PubMed ID: 25564249
[TBL] [Abstract][Full Text] [Related]
18. Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy.
Hommerich L; von Oertzen C; Bedu-Addo G; Holmberg V; Acquah PA; Eggelte TA; Bienzle U; Mockenhaupt FP
Malar J; 2007 Nov; 6():144. PubMed ID: 17996048
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine before and after community delivery of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa: a multi-country evaluation.
Figueroa-Romero A; Bissombolo D; Meremikwu M; Ratsimbasoa A; Sacoor C; Arikpo I; Lemba E; Nhama A; Rakotosaona R; Llach M; Pons-Duran C; Sanz S; Ma L; Doderer-Lang C; Maly C; Roman E; Pagnoni F; Mayor A; Menard D; González R; Menéndez C
Lancet Glob Health; 2023 Nov; 11(11):e1765-e1774. PubMed ID: 37858587
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy, Mansa, Zambia.
Tan KR; Katalenich BL; Mace KE; Nambozi M; Taylor SM; Meshnick SR; Wiegand RE; Chalwe V; Filler SJ; Kamuliwo M; Craig AS
Malar J; 2014 Jun; 13():227. PubMed ID: 24909578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
